Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

Office of Research & Development

 print icon sign up for VA Research updates

VA Participation in the U.S. Centers for Disease Control and Prevention Tecovirimat Investigational New Drug Expanded Access Program for Monkeypox

Veterans Health Administration (VHA) medical facilities may participate in the U.S. Centers for Disease Control and Prevention (CDC) Tecovirimat (TPOXX) Investigational New Drug (IND) Expanded Access Program for Monkeypox under certain conditions, including VHA Medical Facility Director approval; approval by the CDC Institutional Review Board (IRB); and adherence to all CDC IRB and VHA Office of Research and Development (ORD) requirements. Information about the CDC TPOXX IND Expanded Access Program for Monkeypox is maintained by ORD.

To learn more, visit the ORD SharePoint TPOXX site at https://dvagov.sharepoint.com/:u:/r/sites/vacoordresearchpolicy/SitePages/TPOXX-IND-Expanded-Access-Program.aspx?csf=1&web=1&e=Yg2p5W (copy and paste into your browser if you have VA network access), or visit the CDC Tecovirimat (TPOXX) for Treatment of Monkeypox website.



Questions about VA Research or the website? Email VA Research



Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.